Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma
Authors
Fiorenza, SRoutledge, D
Collins, J
Shipton, Michael J
Harrison, S
Bajel, A
Cavet, James
Tholouli, E
Gauthier, J
Ritchie, D
Affiliation
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USAIssue Date
2019
Metadata
Show full item recordCitation
Fiorenza S, Routledge D, Collins J, Shipton M, Harrison S, Bajel A, et al. Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma. Bone Marrow Transplant. 2019 Sep 3.Journal
Bone Marrow TransplantationDOI
10.1038/s41409-019-0642-xPubMed ID
31481801Additional Links
https://dx.doi.org/10.1038/s41409-019-0642-xType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41409-019-0642-x
Scopus Count
Collections
Related articles
- American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
- Authors: Giralt S, Garderet L, Durie B, Cook G, Gahrton G, Bruno B, Hari P, Lokhorst H, McCarthy P, Krishnan A, Sonneveld P, Goldschmidt H, Jagannath S, Barlogie B, Mateos M, Gimsing P, Sezer O, Mikhael J, Lu J, Dimopoulos M, Mazumder A, Palumbo A, Abonour R, Anderson K, Attal M, Blade J, Bird J, Cavo M, Comenzo R, de la Rubia J, Einsele H, Garcia-Sanz R, Hillengass J, Holstein S, Johnsen HE, Joshua D, Koehne G, Kumar S, Kyle R, Leleu X, Lonial S, Ludwig H, Nahi H, Nooka A, Orlowski R, Rajkumar V, Reiman A, Richardson P, Riva E, San Miguel J, Turreson I, Usmani S, Vesole D, Bensinger W, Qazilbash M, Efebera Y, Mohty M, Gasparreto C, Gajewski J, LeMaistre CF, Bredeson C, Moreau P, Pasquini M, Kroeger N, Stadtmauer E
- Issue date: 2015 Dec
- The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
- Authors: Kyle RA
- Issue date: 2000
- Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
- Authors: El-Jawahri A, Chen YB, Brazauskas R, He N, Lee SJ, Knight JM, Majhail N, Buchbinder D, Schears RM, Wirk BM, Wood WA, Ahmed I, Aljurf M, Szer J, Beattie SM, Battiwalla M, Dandoy C, Diaz MA, D'Souza A, Freytes CO, Gajewski J, Gergis U, Hashmi SK, Jakubowski A, Kamble RT, Kindwall-Keller T, Lazarus HM, Malone AK, Marks DI, Meehan K, Savani BN, Olsson RF, Rizzieri D, Steinberg A, Speckhart D, Szwajcer D, Schoemans H, Seo S, Ustun C, Atsuta Y, Dalal J, Sales-Bonfim C, Khera N, Hahn T, Saber W
- Issue date: 2017 May 15
- Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
- Authors: Nishihori T, Alsina M
- Issue date: 2011 Oct
- Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
- Authors: Fabre C, Koscielny S, Mohty M, Fegueux N, Blaise D, Maillard N, Tabrizi R, Michallet M, Socié G, Yakoub-Agha I, Garban F, Uzunov M, François S, Contentin N, Lapusan S, Bourhis JH
- Issue date: 2012 Apr